Traditional MedicareCoverageMedium impact
Biofeedback and Neurofeedback
BCBS Tennessee·Family Medicine, Internal Medicine, Gastroenterology +6 more·Medical Policy
Effective date
Oct 31, 2026
We identified it
Aug 14, 2026
Summary
This new policy defines medical necessity criteria for biofeedback and neurofeedback treatments. Biofeedback is covered only for migraine/tension headaches, constipation, urinary incontinence, and fecal incontinence when specific clinical criteria are met. Neurofeedback and biofeedback for all other conditions remain investigational and non-covered. Medicare Advantage plans are explicitly excluded from this policy.
Action Required
By October 31, 2026: Billing team must update claim adjudication rules to enforce medical necessity criteria for biofeedback claims. (1) For migraine/tension headache biofeedback: Require documentation of failed pharmacologic treatment and limit to 20 sessions per 12 months. (2) For constipation biofeedback: Require 3-month failed conservative treatment documentation and pelvic floor dyssynergia confirmation; limit to 6 sessions over 3 months. (3) For urinary incontinence biofeedback: Require cognitive status confirmation, failed conservative treatment, and completion of 4-week pelvic muscle training. (4) For fecal incontinence biofeedback: Require sphincter contractility, rectal sensation documentation, and failed conservative treatment. (5) Deny all neurofeedback claims as investigational. (6) Deny home biofeedback for urinary incontinence as investigational. (7) Deny biofeedback for all conditions not listed as medically appropriate. (8) Configure system to EXCLUDE Medicare Advantage beneficiaries from this policy entirely. Update billing software validation rules, encounter templates, and prior authorization workflows. Train billing and authorization staff on new criteria. Failure to implement will result in incorrect claim denials or improper payments.